Long-Term Follow-up of Ibrutinib Treatment for Rituximab-Refractory Waldenström’s Macroglobulinemia: Final Analysis of the Open-Label Substudy of the Phase 3 iNNOVATETM Trial

Judith Trotman; Christian Buske; Alessandra Tedeschi; Jeffrey V. Matous; David MacDonald; Constantine Tam; Olivier Tournilhac; Shuo Ma; Steven P. Treon; Albert Oriol; Jerry Ping; Eva M. Briso; Israel Arango-Hisijara; Meletios A. Dimopoulos

doi:10.1182/BLOOD-2020-133916

Long-Term Follow-up of Ibrutinib Treatment for Rituximab-Refractory Waldenström’s Macroglobulinemia: Final Analysis of the Open-Label Substudy of the Phase 3 iNNOVATETM Trial

Judith Trotman
, Christian Buske
, Alessandra Tedeschi
, Jeffrey V. Matous
, David MacDonald
, Constantine Tam
, Olivier Tournilhac
, Shuo Ma
, Steven P. Treon
, Albert Oriol
, Jerry Ping
, Eva M. Briso
, Israel Arango-Hisijara
, Meletios A. Dimopoulos

Concord Hospital
Comprehensive Cancer Center Ulm, Ulm, Germany
ASST Niguarda (Grande Ospedale Metropolitano Niguarda), Milano, Italy
Colorado Blood Cancer Institute, Denver, CO
University of Ottawa
Peter MacCallum Cancer Centre
Hématologie Clinique Adulte et Thérapie Cellulaire, CHU Hotel Dieu Hématologie, Clermont-Ferrand, France.
Northwestern University
Harvard University
Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain
Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
Pharmacyclics Switzerland GmbH, an AbbVie Company, Schaffhausen, Switzerland.
National and Kapodistrian University of Athens

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	136
DOIs	https://doi.org/10.1182/BLOOD-2020-133916
State	Published - Nov 5 2020
Externally published	Yes

Disciplines

Medicine and Health Sciences
Family Medicine

Access to Document

10.1182/BLOOD-2020-133916License: Unspecified

Cite this

Trotman, J., Buske, C., Tedeschi, A., Matous, J. V., MacDonald, D., Tam, C., Tournilhac, O., Ma, S., Treon, S. P., Oriol, A., Ping, J., Briso, E. M., Arango-Hisijara, I., & Dimopoulos, M. A. (2020). Long-Term Follow-up of Ibrutinib Treatment for Rituximab-Refractory Waldenström’s Macroglobulinemia: Final Analysis of the Open-Label Substudy of the Phase 3 iNNOVATETM Trial. Blood, 136. https://doi.org/10.1182/BLOOD-2020-133916

Trotman, J, Buske, C, Tedeschi, A, Matous, JV, MacDonald, D, Tam, C, Tournilhac, O, Ma, S, Treon, SP, Oriol, A, Ping, J, Briso, EM, Arango-Hisijara, I & Dimopoulos, MA 2020, 'Long-Term Follow-up of Ibrutinib Treatment for Rituximab-Refractory Waldenström’s Macroglobulinemia: Final Analysis of the Open-Label Substudy of the Phase 3 iNNOVATETM Trial', Blood, vol. 136. https://doi.org/10.1182/BLOOD-2020-133916

@article{4063783cd05a441dafeb57066f7a3fed,

title = "Long-Term Follow-up of Ibrutinib Treatment for Rituximab-Refractory Waldenstr{\"o}m{\textquoteright}s Macroglobulinemia: Final Analysis of the Open-Label Substudy of the Phase 3 iNNOVATETM Trial",

author = "Judith Trotman and Christian Buske and Alessandra Tedeschi and Matous, \{Jeffrey V.\} and David MacDonald and Constantine Tam and Olivier Tournilhac and Shuo Ma and Treon, \{Steven P.\} and Albert Oriol and Jerry Ping and Briso, \{Eva M.\} and Israel Arango-Hisijara and Dimopoulos, \{Meletios A.\}",

note = "Oral and Poster Abstracts 623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma-Clinical Studies: Poster III Biological, Diseases, Therapies, B-Cell Lymphoma, Lymphoid Malignancies, TKI Judith Trotman, FRACP 1, Christian Buske, MD 2, Alessandra Tedeschi, MD 3 *, Jeffrey V.",

year = "2020",

month = nov,

day = "5",

doi = "10.1182/BLOOD-2020-133916",

language = "American English",

volume = "136",

journal = "Blood",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Long-Term Follow-up of Ibrutinib Treatment for Rituximab-Refractory Waldenström’s Macroglobulinemia: Final Analysis of the Open-Label Substudy of the Phase 3 iNNOVATETM Trial

AU - Trotman, Judith

AU - Buske, Christian

AU - Tedeschi, Alessandra

AU - Matous, Jeffrey V.

AU - MacDonald, David

AU - Tam, Constantine

AU - Tournilhac, Olivier

AU - Ma, Shuo

AU - Treon, Steven P.

AU - Oriol, Albert

AU - Ping, Jerry

AU - Briso, Eva M.

AU - Arango-Hisijara, Israel

AU - Dimopoulos, Meletios A.

N1 - Oral and Poster Abstracts 623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma-Clinical Studies: Poster III Biological, Diseases, Therapies, B-Cell Lymphoma, Lymphoid Malignancies, TKI Judith Trotman, FRACP 1, Christian Buske, MD 2, Alessandra Tedeschi, MD 3 *, Jeffrey V.

PY - 2020/11/5

Y1 - 2020/11/5

UR - https://ash.confex.com/ash/2020/webprogram/Paper133916.html

U2 - 10.1182/BLOOD-2020-133916

DO - 10.1182/BLOOD-2020-133916

M3 - Article

VL - 136

JO - Blood

JF - Blood

ER -

Long-Term Follow-up of Ibrutinib Treatment for Rituximab-Refractory Waldenström’s Macroglobulinemia: Final Analysis of the Open-Label Substudy of the Phase 3 iNNOVATETM Trial

Disciplines

Access to Document

Other files and links

Cite this